Tanvex BioPharma
6541.TW
1.30 USD
0.01
+0.78%
t
Overview
Last close
1.30 usd
Market cap
344.27M usd
52 week high
2.50 usd
52 week low
1.25 usd
Target price
1.67 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
27.0828
Price/Book Value
1.9072
Enterprise Value
367.42M usd
EV/Revenue
28.8277
EV/EBITDA
-9.0582
Key financials
Revenue TTM
12.75M usd
Gross Profit TTM
-14.01M usd
EBITDA TTM
-39.59M usd
Earnings per Share
-0.19 usd
Dividend
N/A usd
Total assets
253.63M usd
Net debt
22.29M usd
About
Tanvex BioPharma, Inc., a pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. It also engages in contract development and manufacturing of biological medicines. The company was founded in 2011 and is headquartered in George Town, the Cayman Islands.
- Symbol6541.TW
- ExchangeTW
- IsinKYG8676P1037
- CountryCayman Islands
- SectorHealthcare
- IndustryBiotechnology
- CEO
- HeadquarterGeorge Town
- Web sitehttps://www.tanvex.com
